RECRUITING

Targeted Navigation in Hepatocellular Carcinoma (HCC)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators are trying to learn more about the personal perceptions and experiences regarding the needs of patients with liver cancer to help improve the care of all patients. The investigators would like to know whether there are needs that patients have or are aware of, especially those needs that the investigators have not been able to address. The investigators aim to develop a program that helps participants and participant's families to navigate the process of being diagnosed with liver cancer and receiving treatment.

Official Title

Targeted Navigation to Achieve Health Equity: Increasing Access to Care, Patient Engagement and Research Participation

Quick Facts

Study Start:2024-04-15
Study Completion:2026-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06260943

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * HCC Patients:
  2. * Enrolled or eligible for enrollment in Unified Prospective Registry and Biorepository of Patients with Chronic Liver Disease or Hepatobiliary Cancers Including Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma.
  3. * Diagnosis of hepatocellular carcinoma, confirmed by clinical chart review and International Classification of Diseases, Tenth Revision (ICD-10) C22.0.
  4. * Adults, age 18 or older
  5. * Able to provide informed consent
  6. * All other interviewees:
  7. * Advocates who will self-identify as having had HCC.
  8. * Others who self-identify as either a caregiver or support person of an HCC patient.
  1. * Unable to speak Spanish or English
  2. * West Haven Grade 2 or higher hepatic encephalopathy19 or other cognitive impairment.
  3. * Adults unable or unwilling to consent
  4. * Individuals who are not yet adults (infants, children, teenagers)
  5. * Prisoners
  6. * Given that this study is minimal risk and there are no risks to a potential fetus, investigators will not exclude pregnant women; however, no data about pregnancy or their fetus is being collected

Contacts and Locations

Study Contact

Gloria Figueroa
CONTACT
(305) 243-0779
gef44@med.miami.edu
Patricia Jones, MD
CONTACT
(305) 243-0779
pdjones@med.miami.edu

Principal Investigator

Patricia Jones, MD
PRINCIPAL_INVESTIGATOR
University of Miami

Study Locations (Sites)

University of Miami
Miami, Florida, 33136
United States

Collaborators and Investigators

Sponsor: University of Miami

  • Patricia Jones, MD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-15
Study Completion Date2026-10-31

Study Record Updates

Study Start Date2024-04-15
Study Completion Date2026-10-31

Terms related to this study

Additional Relevant MeSH Terms

  • Hepatocellular Carcinoma
  • Cholangiocarcinoma
  • Hepatobiliary Cancer